TB-500 research leaves human benefit unproved despite some animal gains.
Researchers made a shorter protein chain to study how cells move toward wounds and help repair. Most healing tests gave the source protein, leaving the copied chain’s effects in you unproved.
TB-500 retains the part that holds spare actin for cell movement
Cells move by changing shape, using strands built from a protein called actin. Thymosin beta-4 holds spare actin pieces apart, keeping a reserve ready for use [1][5].
TB-500 copies the stretch that holds actin; that is why repair drew interest. An X-ray study examined this hold after researchers attached another protein part to thymosin beta-4.
The X-ray of prepared proteins showed details 2 angstroms apart, an extremely small distance. This was a study of joined proteins, without patients or injuries being X-rayed.
Thymosin beta-4 and actin paired 1:1, one thymosin beta-4 holding one actin piece [1]. Covering actin's ends stopped the spare actin from joining strands too soon.
Cells can draw on spare pieces when movement is needed near an injury [5]. A review described more vessels and fewer cells making scar tissue after thymosin beta-4 treatment [5].
Fewer cells died, and inflammation, the body's often painful injury response, decreased [5]. You still lack human evidence that the copied chain produces those same repair effects.
TB-500 benefits claims still need studies of TB-500 itself
The strongest healing finding behind TB-500 benefits claims came from rats given thymosin beta-4. Most other findings involved animals or cells, leaving your benefit from TB-500 unanswered.
The rats grew +42% more covering skin after 4 days of treatment. At 7 days, growth was +61% above wounds treated with salt water [3].
Narrower wounds had added blood vessels and collagen, which lends strength to skin. In mice with a blocked heart artery, thymosin beta-4 improved the survival of heart cells [2].
Heart pumping improved, and cells moved toward damage in mice given thymosin beta-4. Other experiments found that thymosin beta-4 encouraged the growth of additional blood vessels [10].
During wound repair, proteins that remove old tissue became more plentiful [11]. All these findings concern the longer protein, so they don't establish healing from the copied chain for you [5].
The largest amount tested did not clearly help rats after stroke
Researchers blocked a brain artery in male rats, causing strokes in those animals. The rats received thymosin beta-4 in shots around their belly organs.
Different rat groups tested 2, 12, or 18 milligrams per kilogram, a measure of body weight. The first treatment came 24 hours after stroke; four further treatments followed every 3 days.
Using body weight to set amounts meant larger rats received more thymosin beta-4. Rats given 2 or 12 milligrams per kilogram had better results when researchers tested brain function.
Those gains were clear from day 14 to day 56 of the study. Rats given 18 milligrams per kilogram showed no clear benefit on those tests [4].
The largest amount didn't help clearly, questioning users' claims for high starting amounts [4]. You can't assume that giving more will lead to more useful repair.
The experiment studied stroke recovery in rats receiving the longer protein, not the copied chain. You can't use the study to establish a treatment amount for the copied chain.
Growth in mice and treatment in pigs failed to restore useful function
Mice missing a muscle protein received 150 micrograms of thymosin beta-4 twice weekly for 6 months. A gram contains a million micrograms, so those amounts were small.
Their muscle fibers increased, but their strength didn't improve with treatment [9]. Heart pumping and scarring didn't improve either; extra growth failed to restore function.
In pigs, researchers stopped heart blood flow and then restored the flow. Thymosin beta-4 didn't reduce the heart damage caused by that stoppage and return [14].
Separate rodent experiments with thymosin beta-4 found heart protection after researchers stopped blood from reaching the heart [13]. These weren't identical tests, so protection in rodents didn't settle the pig result.
A 2026 review assessed injury and sports claims for peptides, short protein chains. The unapproved substances discussed included TB-500, thymosin beta-4, and BPC-157 [15].
Many animal findings looked hopeful, but careful human safety studies were scarce. Your choice still faces possible serious harm and limited checks on these substances.
Human TB-500 studies have not supplied a finished comparison of treatments
TB-500 lacks a finished human trial comparing treatment with other care [5]. Thymosin beta-4 was given through a vein in the early safety test, Phase 1.
The 40 healthy volunteers tolerated amounts up to 1260 milligrams [6]. The cited review mentions thymosin beta-4 dry-eye trials without giving their findings [5].
The review also notes a completed study of shots after heart attack. The review doesn't report that study's findings; another study ended before anyone enrolled [5].
Missing findings don't tell you whether treatment helped or failed in that study. The human research concerns thymosin beta-4 and leaves healing from TB-500 unproved [5].
TB-500 heart claims cannot resolve the different results in mice and pigs
Mice with a blocked heart artery had better pumping and cell survival after thymosin beta-4 [2]. Separate rodent work found protection after the heart's blood supply was interrupted [13].
In pigs, thymosin beta-4 didn't reduce damage from stopping and restoring heart blood flow [14]. These different animal tests used thymosin beta-4, leaving your benefit from the copied chain unproved.
TB-500 stroke claims have no finding of benefit in people
Rats recovering from stroke improved with thymosin beta-4 at 2 and 12 milligrams per kilogram. The rats given 18 milligrams per kilogram showed no clear gain [4].
Each treatment amount was set using the weight of the rat. You can't judge a treatment by another protein's effects in a rat.
TB-500 hair hopes come from changes near animal hair roots
Thymosin beta-4 made immature cells near rat and mouse hair roots move and develop [5][11]. Hair grew as proteins that clear surrounding tissue increased, allowing cells to move.
That clearing concerns changes around roots as the hair grows. TB-500 hasn't shown hair regrowth in people like you [5].
TB-500 relief from inflammation remains unproved despite early eye findings
Eye experiments found thymosin beta-4 reduced activity tied to inflammation, your body's injury response, often causing sore, swollen tissue [12]. A review described less inflammation after injury too [5].
Researchers tested animals and laboratory cells, leaving human relief unknown for you. You don't yet have human proof that the copied chain eases painful swelling.
TB-500 wound claims cite rats that received the longer protein
Deep wounds in rats grew 42% more covering skin after 4 days of thymosin beta-4. After 7 days, growth was up to 61% above wounds given salt water.
More blood vessels appeared, along with collagen, which adds strength to skin. Skin cells in dishes moved more with 10 picograms, each a trillionth of a gram [3].
TB-500 muscle recovery needs evidence of strength as well as growth
In animals, thymosin beta-4 drew cells that make muscle toward damaged areas [5]. A 6-month mouse experiment found more muscle fibers, without greater strength [9].
Human trials haven't proved that TB-500 restores useful movement after an injury [5]. Exercise releases thymosin beta-4, which helped draw researchers' interest toward muscle repair.
Your recovery depends on what the muscle can do after healing. More growth in animals receiving another substance doesn't establish faster recovery for you.